Ignite Creation Date:
2024-05-06 @ 3:57 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02410421
Status:
WITHDRAWN
Last Update Posted:
2016-01-05
First Post:
2015-04-01
Brief Title:
e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Validation of Individualized rTMS Protocol Using Non Invasive Functional Brain Imaging and Robotic Coil Placement in Resistant Depression Comparison With Classical rTMS and tDCS
Status:
WITHDRAWN
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Although repetitive trans-cranial magnetic stimulation rTMS is an effective therapy for resistant depression it still fail to remit up to 70 of these patients We hypothesize that personalizing the procedure using functional MRI to better select dysfunctional regions and robotic coil placement to stimulate these regions homogeneously will increase its efficacy Individualized rTMS will be compared to traditional rTMS procedure and to trans-cranial direct current stimulation tDCS
In this small proof of principle study our primary outcome measure will be the correction of the MRI anomalies Symptoms reduction and the proportion of remitters will be secondary outcome measurements
In this small proof of principle study our primary outcome measure will be the correction of the MRI anomalies Symptoms reduction and the proportion of remitters will be secondary outcome measurements
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None